Ciba Specialty Chemicals to partner with Biosignal Ltd for antibiofilm products

Novel antibiofilm technology mimics natural defenses seen in seaweed

05-Apr-2006

Ciba specialty chemicals announced the completion of a joint development and licensing agreement with Biosignal, Sydney, Australia to develop novel antimicrobial compounds for consumer and industrial products based upon Biosignal's antibiofilm technology. Biosignal has granted Ciba Specialty Chemicals an exclusive license in some of Ciba's key markets including plastics, coatings, paints, fibres and paper products.

The formation of biofilms in many industrial environments can lead to fouling, corrosion, material degradation and general contamination. Biosignal's antibiofilm technology is based on a discovery that the eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacteria's ability to colonize.

Development is expected to begin next month and testing will occur at Ciba's laboratories in Basel, Switzerland and at Biosignal's laboratories in Sydney, Australia.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!